Nyxoah (NASDAQ:NYXH) vs. Aspyra (OTCMKTS:APYI) Critical Survey

Aspyra (OTCMKTS:APYI) and Nyxoah (NASDAQ:NYXH) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

Earnings & Valuation

This table compares Aspyra and Nyxoah”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aspyra	N/A	N/A	N/A	N/A	N/A
Nyxoah	$11.33 million	11.15	-$101.92 million	($2.68)	-1.22

Aspyra has higher earnings, but lower revenue than Nyxoah.

Profitability

This table compares Aspyra and Nyxoah’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aspyra	N/A	N/A	N/A
Nyxoah	-884.69%	-139.18%	-79.53%

Analyst Ratings

This is a breakdown of current ratings and price targets for Aspyra and Nyxoah, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aspyra	0	0	0	0	0.00
Nyxoah	1	0	3	0	2.50

Nyxoah has a consensus price target of $9.33, suggesting a potential upside of 186.30%. Given Nyxoah’s stronger consensus rating and higher possible upside, analysts clearly believe Nyxoah is more favorable than Aspyra.

Volatility and Risk

Aspyra has a beta of -0.08, suggesting that its share price is 108% less volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500.

Summary

Nyxoah beats Aspyra on 5 of the 8 factors compared between the two stocks.

About Aspyra

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.